News
One study reported 8 live births from 22 women with pathogenic mtDNA variants who underwent mitochondrial donation through pronuclear transfer. None had signs of mitochondrial disease and heteroplasmy ...
One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling
One Biosciences ("One Biosciences" or the "Company"), a precision oncology techbio company pioneering clinical grade single-cell tumor transcriptomic profiling, today announced a €15 million Series A ...
One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell transcriptomic platform, ...
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...
Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 7, ...
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...
Genomics is transforming viticulture by enabling sustainable grape cultivation in the face of climate change and pest ...
22h
Capital Market on MSNBarometers end near flat line; Nifty closes above 25,200 markThe key benchmark indices ended with small gains today, witnessing mild buying interest despite Donald Trump announced a 19% tariff on products that Indonesia sells to the United States. Further Trump ...
The content creator rocked the character's skintight white plug suit. The latex masterpiece, crafted by Andromeda Latex, even featured the black and orange detailing. She completed the look with Rei's ...
21h
Capital Market on MSNSensex and Nifty inch ahead amid blurry global signalsEquity benchmarks ended with modest gains on Tuesday, with the Nifty closing above the 25,200 mark. PSU banks and IT stocks attracted buying interest, while metal and pharma shares faced selling ...
Praxis Precision Medicines said federal regulators have granted their breakthrough therapy designation, or BTD, to its seizure treatment, relutrigine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results